Nurix Therapeutics (NRIX) EBT Margin Growth (3y) (2022 - 2026)
Powered by 
Analysis
Nurix Therapeutics (NRIX) EBT Margin Growth (3y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | -484.00 |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 132.00 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 6,691.00 |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | -2,054.00 |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 8,006.00 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 9,980.00 |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | -5,319.00 |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 31,363.00 |
| 10 | Nurix Therapeutics | 2.86 Bn | 2.42 Bn | - | -91,396.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -91,396.00 |
| Feb 28, 2026 | -107,323.00 |
| Nov 30, 2025 | 11,261.00 |
| Aug 31, 2025 | -67,118.00 |
| May 31, 2025 | 30,021.00 |
| Feb 28, 2025 | 13,671.00 |
| Nov 30, 2024 | 6,848.00 |
| Aug 31, 2024 | -10,580.00 |
| May 31, 2024 | 244.00 |
| Feb 29, 2024 | 23,323.00 |
| Nov 30, 2023 | 2,033.00 |
| Aug 31, 2023 | 25,303.00 |
| May 31, 2023 | 23,188.00 |
| Feb 28, 2023 | 11,115.00 |
| Nov 30, 2022 | 2,603.00 |
| Aug 31, 2022 | -40,074.00 |